Certain Litigation Charges, Net	9 Months Ended
Jan. 27, 2012
Certain Litigation Charges Note [Abstract]
Certain Litigation Charges, Net	Note 5 – Certain Litigation Charges, Net The Company classifies material litigation reserves and gains recognized as certain litigation charges, net. During the three and nine months ended January 27, 2012, there were no certain litigation charges, net. During the three months ended January 28, 2011, the Company recorded certain litigation charges, net of $13 million related to a charge for Other Matters litigation. During the nine months ended January 28, 2011, the Company recorded certain litigation charges, net of $292 million related primarily to a settlement involving the Sprint Fidelis family of defibrillation leads and charges for Other Matters litigation. The Sprint Fidelis settlement related to the resolution of certain outstanding product liability litigation related to the Sprint Fidelis family of defibrillation leads that were subject to a field action announced October 15, 2007. The parties subsequently reached an adjusted settlement agreement to pay a total of $221 million to resolve over 14,000 filed and unfiled claims and the Company paid out the settlement in the third quarter of fiscal year 2012. The Company also paid out the settlement in the third quarter of fiscal year 2012 from the reserve taken in fiscal year 2011 for the Other Matters litigation. See Note 20 for additional information.

Certain Litigation Charges, Net

9 Months Ended

Jan. 27, 2012

Certain Litigation Charges Note [Abstract]

Note 5 – Certain Litigation Charges, Net

The Company classifies material litigation reserves and gains recognized as certain litigation charges, net. During the three and nine months ended January 27, 2012, there were no certain litigation charges, net.

During the three months ended January 28, 2011, the Company recorded certain litigation charges, net of $13 million related to a charge for Other Matters litigation.

During the nine months ended January 28, 2011, the Company recorded certain litigation charges, net of $292 million related primarily to a settlement involving the Sprint Fidelis family of defibrillation leads and charges for Other Matters litigation. The Sprint Fidelis settlement related to the resolution of certain outstanding product liability litigation related to the Sprint Fidelis family of defibrillation leads that were subject to a field action announced October 15, 2007. The parties subsequently reached an adjusted settlement agreement to pay a total of $221 million to resolve over 14,000 filed and unfiled claims and the Company paid out the settlement in the third quarter of fiscal year 2012. The Company also paid out the settlement in the third quarter of fiscal year 2012 from the reserve taken in fiscal year 2011 for the Other Matters litigation. See Note 20 for additional information.